Casdin Capital’s Hims & Hers Health HIMS Stock Holding History

Casdin Capital’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24.3M	Hold	700,000	–	–	1.21%	17
2026 Q1	$14.5M	Buy	700,000 +315,000	+82%	+$7.44M	1.1%	17
2025 Q4	$12.5M	Buy	385,000 +155,000	+67%	+$6.64M	0.78%	20
2025 Q3	$13M	Hold	230,000	–	–	1.09%	16
2025 Q2	$11.5M	Buy	230,000 +30,000	+15%	+$1.36M	1.04%	16
2025 Q1	$5.91M	Buy	+200,000	New	+$7.43M	0.48%	28

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Casdin Capital's HIMS Position: Q2 2026 in Review

Casdin Capital held its Hims & Hers Health (HIMS) position steady in Q2 2026 at 700,000 shares worth $24.3M. The position accounts for 1.21% of the portfolio, ranked #17.

Casdin Capital first reported a position in HIMS in Q1 2025 and has held it in 6 quarters since. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

Casdin Capital held 700,000 shares of Hims & Hers Health worth $24.3M as of Q2 2026.
Casdin Capital left its Hims & Hers Health share count unchanged in Q2 2026.
Hims & Hers Health made up 1.21% of Casdin Capital's portfolio in Q2 2026, its #17 holding.
Casdin Capital first reported a position in Hims & Hers Health in Q1 2025 and has held it in 6 quarters since.
506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Casdin Capital's 13F filing for Q2 2026, filed 14 Aug 2026.